NEW YORK (GenomeWeb News) – Though it was a mixed month on the stock market for firms in the genomic tools and molecular diagnostics industries, Nanosphere and Cepheid managed significant gains, while Complete Genomics continued to struggle.

Overall, the GenomeWeb Daily News Index climbed 2 percent for the month of June, bouncing back from a more than 3 percent decline in May. Seventeen of the 30 firms in the Index saw their shares rise for the month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.